Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (271-280 of 450) with videos related to

Pageof 45
Sort By:
European Journal of Human Genetics : EJHG|November 17, 2005
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC softwareCarlo Capalbo, Enrico Ricevuto, Annarita Vestri, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-aDaniele Simoni, Riccardo Rondanin, Paolo Marchetti, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 25, 2015
Early onset pancreatic cancer: risk factors, presentation and outcomeMatteo Piciucchi, Gabriele Capurso, Roberto Valente, et al.
Pigment Cell & Melanoma Research|June 1, 2025
Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World StudySilvia Mezi, Andrea Botticelli, Giulia Pomati, et al.
Cancers|September 19, 2020
Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast CancerBruna Cerbelli, Simone Scagnoli, Silvia Mezi, et al.
European Journal of Clinical Pharmacology|November 20, 2016
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant CapecitabineMichela Roberto, Adriana Romiti, Andrea Botticelli, et al.
Cancers|September 28, 2023
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic MelanomaSilvia Mezi, Andrea Botticelli, Simone Scagnoli, et al.
Frontiers in Immunology|August 26, 2021
Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-AnalysisAndrea Botticelli, Alessio Cirillo, Lidia Strigari, et al.
Tumori|March 10, 2010
The medical oncologist's role in palliative care: AIOM's positionVittorina Zagonel, Luigi Cavanna, Gianluigi Cetto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 16, 2017
Nutritional support for cancer patients: still a neglected right?Riccardo Caccialanza, Francesco De Lorenzo, Luca Gianotti, et al.
Pageof 45

Showing results (271-280 of 450) with videos related to

Sort By:
Pageof 45
European Journal of Human Genetics : EJHG|November 17, 2005
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC softwareCarlo Capalbo, Enrico Ricevuto, Annarita Vestri, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-aDaniele Simoni, Riccardo Rondanin, Paolo Marchetti, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 25, 2015
Early onset pancreatic cancer: risk factors, presentation and outcomeMatteo Piciucchi, Gabriele Capurso, Roberto Valente, et al.
Pigment Cell & Melanoma Research|June 1, 2025
Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World StudySilvia Mezi, Andrea Botticelli, Giulia Pomati, et al.
Cancers|September 19, 2020
Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast CancerBruna Cerbelli, Simone Scagnoli, Silvia Mezi, et al.
European Journal of Clinical Pharmacology|November 20, 2016
Evaluation of 5-fluorouracil degradation rate and Pharmacogenetic profiling to predict toxicity following adjuvant CapecitabineMichela Roberto, Adriana Romiti, Andrea Botticelli, et al.
Cancers|September 28, 2023
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic MelanomaSilvia Mezi, Andrea Botticelli, Simone Scagnoli, et al.
Frontiers in Immunology|August 26, 2021
Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-AnalysisAndrea Botticelli, Alessio Cirillo, Lidia Strigari, et al.
Tumori|March 10, 2010
The medical oncologist's role in palliative care: AIOM's positionVittorina Zagonel, Luigi Cavanna, Gianluigi Cetto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 16, 2017
Nutritional support for cancer patients: still a neglected right?Riccardo Caccialanza, Francesco De Lorenzo, Luca Gianotti, et al.
Pageof 45